ПРОВОСПАЛИТЕЛЬНЫЕ ЦИТОКИНЫ IL-4 И IL-13 У ДЕТЕЙ С "НЕСЕКРЕТАНТНЫМ" И "СЕКРЕТАНТНЫМ" СТАТУСОМ АНТИГЕНА "Н" ПРИ ПИЩЕВОЙ АЛЛЕРГИИ

  • N. Kosyakova Hospital of Pushchino Scientific Center of Russian Academy of Sciences
  • I. Prokhorenko Institute of Basic Biological Problems of the Russian Academy of Sciences – A Separate Subdivision of PSCBR RAS (IBBP RAS)
Ключевые слова: пищевая аллергия, дети, цитокины, антиген Н.

Аннотация

Проведен анализ особенностей продукции провоспалительных цитокинов IL-4 и IL-13 у детей с верифицированным диагнозом «Пищевая аллергия», имеющих "секретантный" и "несекретантный" статус по Н антигену. Показано, что у детей с "несекретантным" статусом содержание IL-4 в сыворотке крови, как маркера Тh2 воспаления, в 1,7 раза выше, чем у детей с "секретантным" статусом. Содержание IL-13 было также повышено, но не столь значительно. У детей с "несекретантным" статусом более высокий уровень содержания провоспалительных цитокинов коррелировал с более тяжелым течением аллергического воспаления, что позволило считать определение Н антигена в слюне детей и их матерей не инвазивным маркером в прогнозе течения аллергического воспаления у детей с пищевой аллергией. 

Биографии авторов

N. Kosyakova , Hospital of Pushchino Scientific Center of Russian Academy of Sciences

Medicine Doctor, Deputy for Science, Head of the Department of Immunology and Allergology

I. Prokhorenko , Institute of Basic Biological Problems of the Russian Academy of Sciences – A Separate Subdivision of PSCBR RAS (IBBP RAS)

 Doctor of Science in Biology, Chief Researcher of the Laboratory of Molecular Biomedicine

Литература

Guerra S, Lohman I, Halonen M et al. Reduced Interferon g Production and Soluble CD14 Levels in Early Life Predict Recurrent Wheezing by 1 Year of Age. American Journal of Respiratory and Critical Care Medicine. 2004; 169(1):70-76.

Hershey G, Friedrich M, Esswein L et al. The Association of Atopy with a Gain-of-Function Mutation in the a Subunit of the Interleukin-4 Receptor. New England Journal of Medicine. 1997; 337(24):1720-1725.

5. Xie M, Dent A. Interleukin-13 Is Unlucky for Allergy Sufferers. Trends in Pharmacological Sciences. 2019; 40(10):714-716.

Camelo A, Rosignoli G, Ohne Y et al. IL-33, IL25, and TSLP induce a distinct phenotypic and activation profile in human type 2 innate lymphoid cells. Blood Advances. 2017; 1(10):577-589.

Montaldo E, Vacca P, Vitale C et al. Human innate lymphoid cells. Immunology Letters. 2016; 179:2-8.

Chudakov D. B., Svirshevskaya E. V. Rol vrozhdennogo immuniteta pri allergii // Rossijskij immunologicheskij zhurnal. – 2015. – T. 9. – №. 3. – S. 298-306. [D. B. Chudakov and E. V. Svirshchevskaya, “The role of innate immunity in allergy”, Russian Journal of Immunology, vol. 9, no. 18, pp. 298–306, 2015].

Artis D, Spits H. The biology of innate lymphoid cells. Nature. 2015; 517 (7534):293-301.

Hepworth M, Sonnenberg G. Regulation of the adaptive immune system by innate lymphoid cells. Current Opinion in Immunology. 2014; 27:75-82.

Chereshnev V.A., Chereshneva M.V.. Immunologicheskie mehanizmy mestnogo vospaleniya // Medicinskaya immunologiya. – 2011. – T. 13. – S. 557–568. [V. A. Chereshnev and M. V. Chereshneva, “Immunological mechanisms of local inflammation”, Medical Immunology (Russia), vol. 13, no. 6, pp. 557–568, 2011]. 10 Kalliomaki M, Salminen S, Arvilommi H et al. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. The Lancet. 2001; 357(9262):1076-1079.

Tanaka M, Nakayama J. Development of the gut microbiota in infancy and its impact on health in later life. Allergology International. 2017; 66(4): 515-522.

Berni Canani R, Gilbert J, Nagler C. The role of the commensal microbiota in the regulation of tolerance to dietary allergens. Current Opinion in Allergy & Clinical Immunology. 2015; 15(3):243-249.

Kosyakova N.I, Andreeva L.A., Pankratova E.V. Poisk novyh sposobov diagnostiki pishevoj allergii i pishevoj neperenosimosti u detej // Mezhdunarodnyj zhurnal prikladnyh i fundamentalnyh issledovanij. – 2020. – T.9. – S. 32–36. [N. I. Kosyakova, L. A. Andreeva and E. V. Pankratova, “Search for new ways to diagnose food allergies and food intolerance in children”, International Journal of Applied and Fundamental Research (Moscow), vol. 8, pp. 32–36, 2020].

Marionneau S, Cailleau-Thomas A, Rocher J, Le Moullac-Vaidye B, Ruvoen N, Clement M et al. ABH and Lewis histo-blood group antigens, a model for the meaning of oligosaccharide diversity in the face of a changing world. Biochimie. 2001; 83(7):565-573.

Johnston L, Chien K, Bryce P. The Immunology of Food Allergy. The Journal of Immunology. 2014; 192(6):2529-2534.

Sprenger N, Odenwald H, Kukkonen A, Kuitunen M, Savilahti E, Kunz C. FUT2-dependent breast milk oligosaccharides and allergy at 2 and 5 years of age in infants with high hereditary allergy risk. European Journal of Nutrition. 2016; 56(3):1293-1301.

Guidelines for the Diagnosis and Management of Food Allergy in the United States: Report of the NIAID-Sponsored Expert Panel. Journal of Allergy and Clinical Immunology. 2010; 126(6):S1-S58.

Muraro A, Hoffmann-Sommergruber K, Holzhauser T et al. EAACI Food Allergy and Anaphylaxis Guidelines. Protecting consumers with food allergies: understanding food consumption, meeting regulations and identifying unmet needs. Allergy. 2014; 69(11):1464-1472.

Matza L, Swensen A, Flood E et al. Assessment of Health-Related Quality of Life in Children: A Review of Conceptual, Methodological, and Regulatory Issues. Value in Health. 2004; 7(1):79-92. 20 Sommer F, Backhed F. The gut microbiota — masters of host development and physiology. Nature Reviews Microbiology. 2013; 11(4):227-238.

Farup P, Rudi K, Hestad K. Faecal short-chain fatty acids - a diagnostic biomarker for irritable bowel syndrome? BMC Gastroenterology. 2016; 16(1).

McOrist A, Abell G, Cooke C, Nyland K. Bacterial population dynamics and faecal short-chain fatty acid (SCFA) concentrations in healthy humans. British Journal of Nutrition. 2008; 100(1):138-146.

Ardatskaya M. D. i dr. Rol korotkocepochechnyh zhirnyh kislot v ocenke sostoyaniya mikrobiocenoza kishechnika i ego korrekcii u pacientov s NAZhBP razlichnyh stadij // Eksperimentalnaya i klinicheskaya gastroenterologiya. – 2019. – №. 1 (161). [M. D. Ardatskaya, G. V. Garushyan, R. P. Moysak and T. B. Topchiy, “Role of short chain fatty acids in evaluation of gut microbiocenosis disorders and their correction in patients with NAFLD of different stages”, Experimental and Clinical Gastroenterology, vol. 161, no. 1, pp. 106–116, 2019. (In Russ.)]

Rios-Covian D, Ruas-Madiedo P, Margolles A, Gueimonde M, de los Reyes-Gavilan C, Salazar N. Intestinal Short Chain Fatty Acids and their Link with Diet and Human Health. Frontiers in Microbiology. 2016; 7.

Mischke M, Plosch T. More than just a gut instinct–the potential interplay between a baby's nutrition, its gut microbiome, and the epigenome. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 2013; 304(12): R1065-R1069.

Inoue Y, Shimojo N. Microbiome/microbiota and allergies. Seminars in Immunopathology. 2014;37(1):57-64.

Опубликован
2021-11-22
Как цитировать
Kosyakova , N., и I. Prokhorenko. 2021. «ПРОВОСПАЛИТЕЛЬНЫЕ ЦИТОКИНЫ IL-4 И IL-13 У ДЕТЕЙ С "НЕСЕКРЕТАНТНЫМ" И "СЕКРЕТАНТНЫМ" СТАТУСОМ АНТИГЕНА "Н" ПРИ ПИЩЕВОЙ АЛЛЕРГИИ ». EurasianUnionScientists, ноябрь, 24-29. https://doi.org/10.31618/ESU.2413-9335.2021.1.91.1492.